newsinsights

Browse our recent blogs, articles and papers below and sign up here for our regular newsletter. 

Medical Cannabis FAQs

The ETF

What is the Medical Cannabis and Wellness UCITS ETF? 

The Medical Cannabis and Wellness UCITS ETF (CBDX) is designed to track the price and yield performance, before fees and expenses of the Medical Cannabis and Wellness Index. The ETF is fully physically replicated and is available to trade in USD, GBP and EUR on London Stock Exchange and XETRA. The ETF has been issued via the HANetf white-label ETF platform by Purpose Investments.

What Are the Main Features and Key Risks of CBDX?

Advantages:

  • Distinctive: As the first product of its kind in Europe, CBDX provides investors with access to a unique new sector
  • Transparent, modern approach: CBDX follows a rules-based free float weighted index ensuring only investible companies are included in the ETF
  • Diversified: In a single trade, CBDX provides exposure to a basket of companies from US and Canada with high exposure to the medical cannabis theme
  • Governance: CBDX embeds multiple levels of governance and contains constituents engaged in legal, licensed and regulated activities
  • Accessible: Listed on major European exchanges and available on wide variety of execution and broker platforms
  • Legal analysis: During the construction of this ETF there has been significantly more legal analysis across multiple jurisdictions than would occur during the typical ETF product development process, providing reassurance for investors that the fund is in compliance with all relevant local laws and listing standards

 

Key Risks: 

  • The value of equities and equity-related securities can be affected by daily stock and currency market movements
  • Investors' capital is fully at risk and investors may not get back the amount originally invested
  • Exchange rate fluctuations could have a negative or positive effect on returns

 

Who Are Purpose Investments?

Purpose Investments is a Canadian-based asset management company with more than $8 billion in assets under management. Purpose Investments offers a range of managed and quantitative investment products. Purpose Investments is led by well-known entrepreneur Som Seif. Purpose Investments are a pioneer in the provision of cannabis investment funds and have extensive experience researching and trading cannabis securities, having launched the actively managed ‘Purpose Marijuana Opportunities Fund” in 2018.

Why Choose a Cannabis ETF Over Individual Stocks?

Investing in cannabis ETFs may help investors withstand the short-term high price volatility of individual cannabis securities, potentially making for a lower risk more long-term investment. Cannabis ETFs are a way to diversify, investments are split across multiple securities reducing risk and maximising potential profits. ETFs also provide ease of access; investors don’t need to research each individual stock, but can instead invest in a pre-screened basket of Cannabis securities.

Can I Include the CBDX ETF in my SIPP or ISA (UK Clients)?

As with other UCITS ETFs, it is eligible for inclusion in SIPPS and ISAs.

Where Can I Buy the CBDX ETF?

CBDX is available on many major fund supermarkets and investment platforms. For a list of platforms please click here: www.hanetf.com/ecosystem or call HANetf for further information. As with any other investment product, please seek qualified advice before considering an allocation.

EXCHANGE  BB CODE RIC ISIN CURRENCY INCOME
London Stock Exchange CBDX CBDX.L IE00BG5J1N38 USD Acc
London Stock Exchange CBDP CBDP.L IE00BG5J1N38 GBP Acc
XETRA CBSX CBSX.DE DE000A2PPQ08 EUR Acc

 

Cannabis Stocks had a Volatile 2019. Why Invest Now?

We have seen that companies in the cannabis sector have had a kind of gold rush in recent years. The promises of this innovative and dynamic sector sparked the imagination of many investors. Prices rose sharply in 2018 and early 2019. Due to some regulatory setbacks, the sector then missed investors' earnings expectations and subsequently corrected them significantly.

Markets have been keen to challenge expensive valuations and consequently has improved at pricing in anticipated headwinds. The recent sell-off in cannabis stocks has corrected lofty expectations to the extent where the stocks themselves are oversold and once again cheap against their long-term growth and valuation targets. With numerous medical studies now in place and regulatory easing within sight, there are multiple positive catalysts to push the industry forward. The euphoria has come to an end as long-term investors come to join.

The Index Methodology

The Medical Cannabis and Wellness Index is a modified market capitalisation weighted index, calculated by Solactive. The latest guidelines for the Medical Cannabis and Wellness Equity Index (“Index”) can be accessed here

What Types of Companies Does the Index Include?

Index Constituents will compose primarily of three types of businesses.

  • Direct cannabis related activity: this includes businesses engaged in cannabis activity operating in jurisdictions where cannabis is federally legal. Operations can include cultivation, processing, manufacturing, sale and research of cannabis.
  • Indirect cannabis related activity: this includes businesses engaged in hemp and hemp derived-CBD in all jurisdictions where hemp is federally legal. Operations can include cultivation, processing, manufacturing, sale and research of hemp.
  • Ancillary businesses: this includes businesses which are defined as non-plant touching and facilitate the growth and operations of cannabis and hemp related activity in all jurisdictions where it is federally legal to do so.

 

What Are the Definitions Used?

  • Medical: Medical companies are those operating in medical legal jurisdictions and have ZERO exposure to recreational or adult-use cannabis.
  • United States Listings: Exposure is limited to companies operating in the pharmaceutical cannabis space. This list of company includes the likes of GW Pharma, Zynerba Pharma, Cara Therapeutics, Amyris.
  • Canada Listings: very similarly exposure is limited to those operating in medical only jurisdictions such as Columbia Care, Liberty Health and Vireo. Also, Canada based providers of synthetic cannabidiols or pharmaceutical research.
  • Legal: In addition to medical marijuana companies, this condition will add those companies strictly operating in the hemp/CBD business in consumer goods and those providing ancillary services to the cannabis industry such as equipment, processing, manufacturing.
  • CBD/Hemp: The farm bill has made CBD from hemp federally legal in the US and this has also been the case in Europe. We will see the addition of companies such as cbdMD, Isodiol, Hempco to the mix.
  • Ancillary Services: Materials providers such as Scotts MiracleGro and GrowGeneration get added to the mix in addition to consumption equipment providers such as Kushco and Greenlane (both names are non-plant touching and listed in the US).

 

How Often are the Index and CBDX Reviewed and Rebalanced?

The Index and CBDX are reviewed and rebalanced on a quarterly basis. A detailed rebalance calendar is available on the fund page here

How Does the Index Methodology Adapt to Changing Regulations?

The Index and fund methodology enable the addition of securities listed outside U.S. and Canada, as regulatory changes increase the number of medical cannabis securities listed globally.

Screening & Selection

What Restrictions are Used in the Index Methodology?

In order to quality for inclusion in the Index, companies must form part of an investable universe of publicly listed companies with significant business activities in the medical cannabis, hemp and CBD industry (Cannabis Companies). Cannabis Companies must engage in the medical cannabis or cannabis related activities where they are legal in the countries in which they operate.

Sales: No revenue is to be derived from recreational cannabis sales. All revenue must be generated from the above definition of “Strictly Medical AND Legal”. Both conditions of the medical and legal definitions to be met in order to qualify as an investable security. Those medical players operating in federally illegal jurisdictions are excluded. This condition will also exclude ancillary service providers and Hemp-derived CBD processors/manufacturers.

Business activities: Companies with significant business activities in cannabis or cannabis-related services/products. We do not discern the amount of a company’s revenue derived directly from the cannabis or cannabis related activities.

How Are Constituents Screened?

The Index intends to only hold medical cannabis companies, CBD and hemp companies or companies which provide ancillary services to the cannabis sector including hydroponics, equipment and processing. The index is constructed using a rules-based methodology to screen publicly traded securities for cannabis-related activity which are legal under jurisdictions of operation. The starting universe includes companies directly involved in the cannabis trades as well as those providing ancillary services to cannabis-related activity, and the wellness industry around hemp and hemp-derived CBD.

First Level Screening: Exchanges - Securities listed on senior Exchanges (NYSE, NASDAQ, TSX, TSX-V) will forego further screening as these Exchanges require federal legality as a pre-condition of listing.

Second Level Screening: Revenue Trace - For other exchanges which don’t have these listing preconditions, fundamental research will determine whether the company is operating in a jurisdiction with legalised cannabis operations. The Index will disqualify any candidate with cannabis operations which don't comply federal laws where the Candidate operates. If the nature of a company’s business changes, so that they gain exposure to illegal Cannabis, the security will be removed from the Index immediately with intra-period re-constitution.

Third Level Screening: Depositary - The Depository of the Fund also screens and pre-approves all the constituents prior to being included in the portfolio

Fourth Level Screening: Index Administrator - The Index Administrator reviews the resulting companies to ensure the constituents comply with the Index Guidelines.

Regular Reviews and Rebalances

Regular reviews consider whether any of the constituents have expanded operations and have exposure to the recreational cannabis sector. Any breach of the above will result in constituents being ejected from the index and redeemed by the fund, at the earliest opportunity. In addition, the Index is reviewed on a quarterly basis to effectively capture new companies entering the Index Universe.

The Medical Cannabis Market

What Is the Background?

While cannabis has been around for thousands of years, modern science is just beginning to scratch the surface of what’s possible from a medical standpoint. A number of medical uses have already been discovered and studied extensively, with promise shown particular for cancer, AIDS and multiple sclerosis patients. As views and laws surrounding cannabis continue to liberalise around the world, more scientific inquiry will follow. The landscape is not only ripe for further scientific discovery, but also for investors. Cannabis has in essence become a new sort of commodity and an entirely new industry and market has developed relatively quickly in the last decade from a plant that humans have been using for thousands of years. Financial backers no longer shy away from supporting legal cannabis companies. Cannabis is becoming mainstream and, in our view, has great potential to deliver long-lasting social, medical, industrial and economic effects. As of 2018, the global medical cannabis market size was US $13.4 Billion. Experts predict that the market is expected to reach a value of US $148 Billion by 2026, exhibiting a CAGR of 26.4% [1]

Are Cannabis, Hemp and Marijuana the same thing?

Hemp and marijuana are derived from the same Cannabis plant. The difference between the two lies in the THC content; hemp contains ~0.3% TCH, whereas marijuana contains 5 to 20 percent [2].

What’s the Difference Between CBD and THC?

Cannabidiol (CBD) and tetrahydrocannabinol (THC) are both natural compounds of the Cannabis plant. CBD can be found in the form of gels, sweets, oils, supplements, extracts and more. THC is the psychoactive compound in marijuana that gives the sensation of feeling ‘high’. The main difference between the two compounds is that CBD is non-psychoactive, meaning there is no ‘high’ associated with its use [3]. 

What Medical Conditions Can CBD Aid?

CBD is used to help with various conditions, including: 

  • Seizures / Epilepsy
  • Inflammation
  • Pain
  • Psychosis or mental disorders, including depression and anxiety
  • Inflammatory bowel disease
  • nausea
  • migraines
  • Parkinson's disease

 

The number of people suffering from illnesses and diseases that are addressable by CBD is estimated to be in excess of 1 Billion. If just 10% of those affected adopted a CBD-based treatment, it would mean an addressable market of 100 million people [4]. 

Regulation, Legal & Governance

How Did HANetf Ensure that the Fund complies with applicable laws?

The scope of local money laundering rules differs across the EU and some jurisdictions also have extra territoriality provisions. CBDX can and will only invest in cannabis or cannabis related activities where they are legal in the countries in which they operate, and may only supply products and/or perform activities that are legal under applicable national and local laws, including U.S. federal, state and local laws.

HANetf has obtained Irish and English law legal opinions relating to any Money Laundering risks (such as compliance with the UK Proceeds of Crime Act) and launched the Fund based on those positive opinions. If you require more details on the legal due diligence, please contact [email protected]

Are There Existing Market Precedents?

It should be noted that there are UCITS funds, listed on the main exchanges, that currently invest in companies that involved in the legal cannabis sector. Hence there is already precedent for listed UCITS funds holding companies in this sector. We are not aware of any investors or fund sponsors being prosecuted for money laundering as a result of investing in such funds.

What Was the Approval Process with Central Bank of Ireland?

HANetf first started the product development of the Fund during the 3rd quarter of 2018. Given HANetf’s funds are domiciled in Ireland, approached the CBI who confirmed they did not have any objections on policy grounds, to a Medical Cannabis UCITS.

The CBI originally cleared a the Fund by the CBI in January 2019. After a period of further product development involving the various service providers to the Fund, the UCITS Management Company of the Fund, HANetf Management Limited,approved the Fund for launch and. the Fund was approved by the CBI on the 11th November 2019.

How Was Passporting the CDBX Fund Approached?

The first step in order to promote and market the Fund is to passport it to the relevant country. The passport is notified by the CBI to other regulators under the UCITS directive e.g. BAFIN in Germany, CONSOB in Italy and FCA in the UK. This is a fundamental step that is required by regulators before the listing process can begin. As of January 2020, CBDX is passported to the UK, Germany and Italy. It is also available for sale in Ireland as the Fund is domiciled there.

Service Providers

How did HANetf Work with the Depository?

HANetf engaged with the Depository for the Fund as part of the product development process. This process took approximately 18 months as it was developing its own controls and policy over this period. As a global bank, the Depositary has multiple jurisdictions to comply with. CBDX was developed with controls built in to ensure that it met the requirements of the Depositary’s policies, including restrictions as to which exchanges Index constituents could be listed on, plus a review process for adding new securities in CBDX, that also involves sign off from the Depository.

Why Was Purpose Investments Chosen as Fund Partner?

HANetf chose to partner with Purpose Investments LLC on the Fund given their extensive experience in Cannabis investing. Purpose are a pioneer in the provision of broad investment capabilities focused on both traditional and risk-managed alternative investment strategies and have extensive experience researching and trading cannabis securities, having launched their actively managed “Purpose Marijuana Opportunities Fund” in Canada in 2018 [4].

With that experience, they are able to provide a level of additional screening regarding the constituents in the Index to ensure that the companies remain eligible investments, given they are also analysing such companies as part of their active fund management offering.

How did Hanetf Work with Exchanges, Clearing & ICSDS to Ensure a Smooth Pathway to Launch?

HANetf actively engaged with the major European exchanges to understand any concerns they might have with the listing of a medical cannabis fund. Given the legal, regulatory and political environment differs across the EU, HANetf wanted to understand the challenges in the key listing jurisdictions and answer any questions the exchanges had about the Fund and its investment process. Currently, CBDX has been listed in Germany on the Deutche Borse and in the UK on the London Stock Exchange. In order to achieve these listings, the Fund has to meet the requirements of each exchange, and each exchange undertakes its own legal and regulatory due diligence including seeking their own legal opinions regarding compliance with any local laws.

It should be noted that some service providers take a proactive stance on identifying Cannabis related securities. For example:

  • Clearstream ICSD publish a list of cannabis-related securities that are restricted from their settlement and asset servicing services 
  • The financial data firm SIX, which also operates the main Swiss stock exchange, launched “The Marijuana Related Businesses (MRB) Securities”5 service last year which identifies and lists securities that are either directly or indirectly issued by listed MRB entities. The service will also help financial institutions identify the risk level of any given company.

 

Download the pdf version of our Medical Cannabis and Wellness UCITS ETF (CBDX) FAQs here.

Learn more about CBDX

 

Date: 14th February 2020.

Tell us how we can help

Select Investor Type Please Choose one of the Following options to enter the site:

Individual Investor
Institutional Investor

Welcome to HANetf

To start your visit, you have read and accepted our terms and conditions:

HANetf Limited (“HANetf”), is an appointed representative of Mirabella Advisers LLP, which is authorised and regulated by the Financial Conduct Authority (“FCA”).

Our corporate website www.hanetf.com (referred to as the “Site”) is owned by HANetf. By accessing and using the Site you agree to be bound by all terms and conditions which are set out on the Site from time to time, which govern such access and use (the "Terms and Conditions").

Our company number is 10697042. Our registered address is City Tower,  40 Basinghall St, London EC2V 5DE.

This website is for information only. It does not provide investment, tax or legal advice or recommendations.

Use of this Website shall be governed by and construed in accordance with English law and any dispute arising in relation to this Website is subject to the jurisdiction of the English courts.

Distribution of Information:

The distribution of the information and material on this website may be restricted by law in certain countries. None of the information is directed at, or is intended for distribution to, or use by, any person or entity in any jurisdiction (by virtue of nationality, place of residence, domicile or registered office) where publication, distribution or use of such information would be contrary to local law or regulation, or would subject HANetf or any funds it markets to any registration or licensing requirements in such jurisdiction.

You must inform yourself about, and observe any such restrictions in your jurisdiction and by accessing this website you represent that you have done so. The information on this website is not for distribution and does not constitute an offer to sell or the solicitation of any offer to buy any securities in the United States to or for the benefit of any United States person (being residents of the United States or partnerships or corporations organised under the laws thereof). The funds on this Website have not been registered in the United States under the Investment Company Act of 1940 and interests therein are not registered in the United States under the Securities Act of 1933.

Liability & Indemnity:

HANetf is not responsible for the accuracy, completeness or reliability of any data, statistics, commentary or content in any media format on www.hanetf.com. HANetf will not be held responsible for any financial losses incurred as a result of believing the content of materials on this website; or materials and content linked to from this website. Investors should read the Prospectus and KIID and take independent legal, tax and investment advice before investing in any fund.

If you do not comply with the terms and conditions of this website, you may not hold HANetf responsible for any liabilities, losses or damages derived from use of this website.

Risk Warnings:

Never forget that:

  • * The value of securities and funds and the income from them may go up and down and are not guaranteed
  • * You may not get back the amount you invested
  • * Don’t invest in anything based on past performance
  • * Exchange rate changes may impact investment performance
  • * Political actions may impact investment performance
  • * Changes in credit rating may impact investment performance
  • * Changes in tax policies may impact investment performance
  • * Applications to invest should be made on the basis of the relevant prospectus
  • * No materials available on www.hanetf.com constitute investment advice

Specific risk warnings are set out in the prospectus and the supplement for the relevant sub-fund: http://www.hanetf.com/funds/

Website user categorisation

ONLY APPLICABLE IF YOU ARE AN INSTITUTIONAL INVESTOR

The professional investor section of the website and its content is restricted to “Professional Investors” only (as defined below) and is not intended for retail or private investors.

By entering this website, you agree that you are an “Institutional Investor” as defined here: https://www.handbook.fca.org.uk/handbook/COBS/3/5.htmland have read, understood and accepted the conditions.

In accessing the website as a Professional Investor you will be undertaking, warranting and representing to HANetf that you are a Professional Investor. Please note that HANetf will be acting in reliance upon your undertaking, warranty and representation and you shall indemnify us and hold us harmless against all claims liabilities, losses, damages, costs and expenses incurred or suffered by us by reason of any breach of such undertaking, warranty and representation.

As a matter of general policy HANetf will not conduct regulated investment activities with any person as a result of their receiving information from the website, unless agreed otherwise with a professional investor.

Disclaimer:

* Past performance is meaningless and should not be used to judge future performance of any security or fund. Opinions, commentary and estimates reflect a judgement at the date of publication and may not be accurate at the date of reading. Publication of content on www.hanetf.com does not mean the content piece reflects the opinions of HANetf, or its employees, directors or shareholders. HANetf opinions and estimates can change at any time, without notice.

* HANetf does not guarantee the accuracy, consistency, availability, believability or completeness of any data or materials on this website. HANetf may change any data or materials at any time, for any reason without notice.

* The price, value, yield and liquidity of any security or fund can go up and down and may be impacted by Currency Risks, Liquidity Risks, Political Risks, Credit Risks, Tax Risks and Market Risks. Professional advice should be taken before investing in any security or fund.

* HANetf does not guarantee the security of this website. You use this website at your own risk.

* HANetf may change the terms of use for www.hanetf.com at any time, for any reason, without notice.

Cookie Policy:

HANetf will use Cookies to collect data about your computer including browser type, IP address and operating system. HANetf will also monitor your use of www.hanetf.com , including what links you have clicked, what files you download and your behaviour on website pages. We do this to improve our services and serve you materials we believe are relevant to you, and to comply with local regulations. By clicking through, you agree to HANetf using cookies as described here. Please note that you can change your browser settings to delete cookies, but this may impact your experience on www.hanetf.com

Intellectual Property: All content on www.hanetf.com is the intellectual property of HANetf is subject to copyright with all rights reserved and may not be copied, shared, sold, licensed, posted, reproduced or changed without permission of HANetf.

HANetf has the right to change anything on this website without notice or reason.

This website contains numerous registered and unregistered trademarks belonging to the HANetf or our partners. If you are in doubt as to whether an item is a trademark of the HANetf or our partners, please contact us for clarification at the registered office.

Unless otherwise specified, this website and its content are owned by the HANetf, and may contain information, text, graphics, video, software, logos, and other materials ("Content") that are protected by copyright, trademarks, or other proprietary rights. No permission is granted to upload, copy, modify, post, frame, amend or distribute Content in any way without obtaining the prior written permission of HANetf. All intellectual property rights in any part of the world which subsist in the contents of this Website and which belong to HANetf save as expressly granted, hereby reserved Any third party licensor trademarks referenced herein are trademarks of such third party licensor and have been licensed for use by HANetf. The securities incorporating third party indexes are not created, sponsored, endorsed, recommended or promoted by such third party licensors and the licensors shall have any no liability in connection with the securities.

Linked Websites: HANetf may provide links to external websites on www.hanetf.com or in newsletters, publications, content or email communications.

Content on external websites is not controlled by HANetf and users access external Websites at their own risk. A link to a website does not mean HANetf believes, endorses or supports any opinions or information contained on that website.

Monitoring:

Your use of this website may be monitored by HANetf or its service providers, and the resultant information may be used by HANetf for its internal business purposes or in accordance with the rules of any applicable regulatory or self-regulatory organisation.

Governing Law & Jurisdiction:

This legal notice and all issues regarding our Site are governed by English law and are exclusively subject to the English courts.

1.Confidentiality

We will keep your information confidential and only use it within our group (which means our affiliated companies, successors and assigns), and only transfer it to third parties in the manner described in the below section labelled “Use of third parties”, unless we are under a duty to disclose or share your personal data in order to comply with a court order or other legal or regulatory requirement.

2.Personal Data

HANetf will use your personal data only for the purposes and in the manner set forth in this Privacy Policy which describes the steps taken to ensure our processing of your personal data is in compliance with the General Data Protection Regulation ((EU) 2016/679) ("GDPR") and any implementing legislation ("Data Protection Legislation").

How and why we collect personal data

HANetf will use your personal data only for the purposes and in the manner set forth in this Privacy Policy which describes the steps taken to ensure our processing of your personal data is in compliance with the General Data Protection Regulation ((EU) 2016/679) ("GDPR") and any implementing legislation ("Data Protection Legislation").

We will keep your information confidential and only use it within our group (which means our affiliated companies, successors and assigns), unless we are forced to share your personal data to comply with a court order or other legal or regulatory requirement.

The personal information we may collect might include your name, address, email address, company details and any other relevant information that may be included within correspondence. In addition, details of your visits to our website including (but not limited to) IP address, cookies, traffic data, location data, weblogs and other information related to what pages are accessed and when may be collected. Also, for legal reasons, in order to access our website, details of your investor type, and location will be collected, with such collection being carried out in compliance with the Privacy and Electronic Communications Regulations (“PECR”). This data would be collected to customise our users’ visits to our website.

If you are accessing sections of our website that are password protected or have entered the website through a link in an email, our website will identify you as an individual and may collect data including information about the pages you visit, the documents you download or other information to enhance and personalise your future interaction with our website.

Any information collected about you may be associated with other identifying information we hold.

HANetf will retain and process your personal data only when this is necessary to achieve our commercial or business objectives and to comply with our regulatory obligations. After careful consideration, HANetf has concluded the processing of personal data for the reasons mentioned shall be considered necessary, as there would not be another way of achieving the identified interest of the firm.

All information you provide to us is stored on secure servers. Information may be transferred, stored and processed by third parties. It may also be processed by staff operating outside the European Union (“EU”) who work for us or for one of our suppliers of services, such as data processors or providers of back up services. You should be aware that in territories outside the European Economic Area (“EEA”), laws and practices relating to the protection of personal data are likely to be different and, in some cases, may be weaker than those within the EEA. By submitting your personal data, you are agreeing to this transfer, storing or processing.

Such transfers outside the EU will only take place where either (i) the Commission has decided that such third country ensures an adequate level of protection; or (ii) we have provided appropriate safeguards, and on the condition that enforceable rights and effective legal remedies are available for you. If you use our services while you are outside the EU, your information may be transferred outside the EU in order to provide you with those services. By submitting your personal data, you agree to the potential transfer, storing and other processing described above. We will take all steps reasonably necessary to ensure that your personal data are treated securely and in accordance with this Privacy Policy.

3.Use of third parties

Communicating via the internet and sending information to you by other means necessarily involves your personal information passing through or being handled by third parties, but we do not sell or distribute without your permission your personal information to third parties for purposes of allowing them to market products and services to you.

We have also reviewed all key third party agreements where EU personal data is being processed to ensure they are GDPR compliant and that your rights described herein are being protected.

4.What safeguards we have in place

HANetf has security measures in place to protect the loss, misuse and alteration of the information under our control. As no data transmission over the internet can be guaranteed as 100% secure, we cannot ensure or warrant the security of any information you transmit to us and you transfer the data at your own risk. We endeavour to use appropriate security measures, including systems security, backups, business recovery and breach notification procedures, monitoring and testing procedures.

Although we will do our best to protect your personal data, we cannot guarantee the security of your personal data transmitted to our Site and accordingly any transmission is at your own risk. However, once we have received your information, we will use all appropriate procedures and security measures to try to prevent unauthorised access to or disclosure of your personal data.

5.What rights you have with regards to your personal data we process

You have the right to access your personal data and request a copy of the information held by us about you. You also have the right to ask for your information to be transferred to another organisation or to yourself. Where such requests are manifestly unfounded or excessive, we will inform you and we may charge a reasonable fee or refuse to respond to such a request.

You have the right to ask us not to process your personal data for marketing purposes. We will inform you if we intend to use your personal data for such purposes. You can exercise your right to prevent such processing by contacting us directly. You can also exercise the right and change your marketing preferences or restrict any specific uses of your personal data at any time by contacting us.

The accuracy of your information is important to us. We review the information we hold to ensure it is up to date and accurate. You have the right to correct any inaccuracies in the details we hold about you – if you change your email address or notice any other information we hold is inaccurate or out of date, please contact us. You have the right to obtain without undue delay the rectification of any inaccurate personal data concerning you.Your rights to access, rectify, erase or restrict your personal data stated above will be processed by HANetf usually within 30 days of receiving your request. However, HANetf may notify you within such timeframe of an increased time period to process your request and its reason. Where HANetf believes the request is unreasonable it shall notify you and refuse to process your request.

6.Complaints

If you have any questions regarding this Privacy Policy and our privacy practices you can contact us via email at [email protected] or in writing to Compliance, HANetf, City Tower, 40 Basinghall St, London EC2V 5DE.

7.Contact information

If you believe your personal data has been processed by HANetf in a way that does not comply with GDPR, you have the right to lodge a complaint with us directly [email protected] or with a supervisory authority.

If you believe HANetf did not take action on a request you have sent; or informed you without delay and at the latest within one month of receipt of the request of the reasons for not taking action and on the possibility of lodging a complaint with a supervisory authority and seeking a judicial remedy, you have the right to lodge a complaint with a supervisory authority.